Skip to main content

Wildcat Capital Management, LLC

13F filer · CIK 0001582384
Reported Jul 22, 2026
Net buyer this quarter
13F portfolio value$229MU.S. long equity reported on 13F
Positions31 new · 0 closed
Net flow last quarter+$489KBuys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Jul 22, 20263 positions
ULCCFrontier Group Holdings, Inc.$222M97.13%12.19%Not reportedQ2 2024
ALLOAllogene Therapeutics, Inc.$6.08M2.66%0.85%Not reportedQ2 2019
CHYMChime Financial, Inc.$489K0.21%0.04%NewQ2 2026
Q1 2026Reported May 1, 20262 positions
ULCCFrontier Group Holdings, Inc.$99.1M93.29%12.21%Not reportedQ2 2024
ALLOAllogene Therapeutics, Inc.$7.13M6.71%1.19%Not reportedQ2 2019
Q4 2025Reported Feb 3, 20263 positions
ULCCFrontier Group Holdings, Inc.$132M96.86%12.25%Not reportedQ2 2024
ALLOAllogene Therapeutics, Inc.$4M2.93%1.27%Not reportedQ2 2019
PCORProcore Technologies, Inc.$280K0.21%0.00%Not reportedQ3 2021
Q3 2025Reported Nov 14, 20255 positions
ULCCFrontier Group Holdings, Inc.$124M85.40%12.30%Not reportedQ2 2024
RLXRLX Technology Inc.$16.9M11.64%0.41%-64.4%Q1 2021
ALLOAllogene Therapeutics, Inc.$3.62M2.50%1.31%Not reportedQ2 2019
TTANServiceTitan, Inc.$417K0.29%0.01%NewQ3 2025
GTLBGitlab Inc.$264K0.18%Not reportedNot reportedQ3 2022
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.